SCHEMBL25758825

SCHEMBL25758825

CC(C)NC(=O)c1cc2cc(F)c(Cl)cc2[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.63
ALPL P05186 2/20 0.53
EIF4A3 P38919 1/20 0.48
AR P10275 1/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PYGL P06737 3/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
LGALS8 O00214 1/20 0.39
LGALS3 P17931 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24740104 0.94 ALOX15 (0.63) ALOX15ALPLEIF4A3ARMAPT
SCHEMBL25812185 0.84 ALOX15 (0.57) ALOX15ALPLEIF4A3ARMAPT
SCHEMBL1307049 0.81 ALPL (0.52) ALOX15ALPLEIF4A3MAPTKDM4E
SCHEMBL30310681 0.81 ALPL (0.52) ALOX15ALPLEIF4A3MAPTKDM4E
SCHEMBL24740102 0.81 ALOX15 (0.63) ALOX15EIF4A3KDM4EPYGL
SCHEMBL17149721 0.79 MEN1 (0.52) ALOX15ARKDM4EPYGLMEN1
SCHEMBL3639230 0.77 EIF4A3 (0.60) ALOX15ALPLEIF4A3MAPTKDM4E
SCHEMBL23836123 0.77 ALOX15 (1.00) ALOX15ALPLPYGL
SCHEMBL24019694 0.77 ALOX15 (0.70) ALOX15EIF4A3ARKDM4EALDH1A1
SCHEMBL4802001 0.77 ALOX15 (0.79) ALOX15PYGLMEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALOX15 1455/4885ALPL 1886/4885EIF4A3 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.